When Data Meets Doubt: Investigating the FDA Panel’s Rejection of MDMA

Psychedelic Research: The Current Landscape and Future Directions

Understanding Bad Trips: The Power and Potential of Adverse Psychedelic Experiences

Pα+ Psychedelic Bulletin #168:

Ecopsychology, Plant Dietas, and Plant Consciousness: Building a Relationship with Nature

Women’s Health and Psychedelics – New Insights

Regenerative Business in Psychedelics: A Sustainable Path Forward

Meditation, Exploring Spiritual Traditions, and the Wisdom of Plant Medicine

Regulation Beyond Prohibition: RAND Corporation Delivers Report on US Psychedelic Policymaking

Pα+ Psychedelic Bulletin #167: Lykos Insiders, Affiliates Respond to Critics; FDA-Affiliated...

Load more